SG170830A1 - Renin inhibitors for the treatment of hypertension - Google Patents
Renin inhibitors for the treatment of hypertensionInfo
- Publication number
- SG170830A1 SG170830A1 SG201102387-6A SG2011023876A SG170830A1 SG 170830 A1 SG170830 A1 SG 170830A1 SG 2011023876 A SG2011023876 A SG 2011023876A SG 170830 A1 SG170830 A1 SG 170830A1
- Authority
- SG
- Singapore
- Prior art keywords
- hypertension
- treatment
- renin inhibitors
- methods
- cessation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78884206P | 2006-04-03 | 2006-04-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG170830A1 true SG170830A1 (en) | 2011-05-30 |
Family
ID=38420678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG201102387-6A SG170830A1 (en) | 2006-04-03 | 2007-03-30 | Renin inhibitors for the treatment of hypertension |
Country Status (20)
Country | Link |
---|---|
US (1) | US20090062395A1 (pt) |
EP (1) | EP2004167A1 (pt) |
JP (1) | JP2009532494A (pt) |
KR (1) | KR20080108515A (pt) |
CN (1) | CN101415413A (pt) |
AU (1) | AU2007234917B2 (pt) |
BR (1) | BRPI0710095A2 (pt) |
CA (1) | CA2645260A1 (pt) |
CL (1) | CL2007000912A1 (pt) |
IL (1) | IL193905A0 (pt) |
MA (1) | MA30387B1 (pt) |
MX (1) | MX2008012729A (pt) |
NO (1) | NO20084625L (pt) |
NZ (1) | NZ571251A (pt) |
RU (1) | RU2008143055A (pt) |
SG (1) | SG170830A1 (pt) |
TN (1) | TNSN08383A1 (pt) |
TW (1) | TW200806283A (pt) |
WO (1) | WO2007118023A1 (pt) |
ZA (1) | ZA200807615B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009087116A1 (en) * | 2008-01-11 | 2009-07-16 | Novartis Ag | Use of spp100 for the treatment of acute mi |
CN102212012A (zh) * | 2010-04-12 | 2011-10-12 | 上海源力生物技术有限公司 | 一种合成阿利克伦的中间体及其制备方法 |
EP2768971A1 (en) | 2011-10-20 | 2014-08-27 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the detection and the treatment of cardiac remodeling |
CA3137138A1 (en) * | 2019-04-18 | 2020-10-22 | EyePoint Pharmaceuticals, Inc. | Methods of treating hypertension with activators of tie-2 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5659065A (en) * | 1994-04-18 | 1997-08-19 | Novartis Corporation | Alpha-aminoalkanoic acids and reduction products |
US5606078A (en) * | 1994-04-18 | 1997-02-25 | Ciba-Geigy Corporation | 3,5-Disubstituted tetrahydrofuran-2-ones |
MY119161A (en) * | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
US20060013852A1 (en) * | 2002-06-28 | 2006-01-19 | Prescott Margaret F | Use of organic compounds |
US20040266743A1 (en) * | 2003-05-09 | 2004-12-30 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and a renin inhibitor |
US20050209141A1 (en) * | 2003-10-17 | 2005-09-22 | Silver Randi B | Mast cell-derived renin |
PE20142101A1 (es) * | 2004-03-17 | 2014-12-27 | Novartis Ag | Composiciones farmaceuticas de aliskiren |
EP1796725B1 (en) * | 2004-09-27 | 2008-07-23 | Pantarhei Bioscience B.V. | Treatment or prevention of unscheluded bleeding in women on progestogen containing medication |
-
2007
- 2007-03-30 MX MX2008012729A patent/MX2008012729A/es not_active Application Discontinuation
- 2007-03-30 WO PCT/US2007/065564 patent/WO2007118023A1/en active Application Filing
- 2007-03-30 CN CNA2007800124642A patent/CN101415413A/zh active Pending
- 2007-03-30 SG SG201102387-6A patent/SG170830A1/en unknown
- 2007-03-30 AU AU2007234917A patent/AU2007234917B2/en not_active Ceased
- 2007-03-30 CA CA002645260A patent/CA2645260A1/en not_active Abandoned
- 2007-03-30 KR KR1020087024219A patent/KR20080108515A/ko not_active Application Discontinuation
- 2007-03-30 JP JP2009504386A patent/JP2009532494A/ja active Pending
- 2007-03-30 EP EP07759755A patent/EP2004167A1/en not_active Withdrawn
- 2007-03-30 US US12/293,107 patent/US20090062395A1/en not_active Abandoned
- 2007-03-30 RU RU2008143055/14A patent/RU2008143055A/ru unknown
- 2007-03-30 NZ NZ571251A patent/NZ571251A/en not_active IP Right Cessation
- 2007-03-30 BR BRPI0710095-7A patent/BRPI0710095A2/pt not_active IP Right Cessation
- 2007-04-02 TW TW096111640A patent/TW200806283A/zh unknown
- 2007-04-02 CL CL200700912A patent/CL2007000912A1/es unknown
-
2008
- 2008-09-04 ZA ZA200807615A patent/ZA200807615B/xx unknown
- 2008-09-04 IL IL193905A patent/IL193905A0/en unknown
- 2008-09-26 TN TNP2008000383A patent/TNSN08383A1/en unknown
- 2008-10-23 MA MA31327A patent/MA30387B1/fr unknown
- 2008-11-03 NO NO20084625A patent/NO20084625L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200806283A (en) | 2008-02-01 |
BRPI0710095A2 (pt) | 2011-08-02 |
KR20080108515A (ko) | 2008-12-15 |
CA2645260A1 (en) | 2007-10-18 |
MX2008012729A (es) | 2008-10-14 |
ZA200807615B (en) | 2009-10-28 |
IL193905A0 (en) | 2009-08-03 |
US20090062395A1 (en) | 2009-03-05 |
NO20084625L (no) | 2008-11-03 |
CL2007000912A1 (es) | 2008-03-14 |
NZ571251A (en) | 2011-12-22 |
MA30387B1 (fr) | 2009-05-04 |
TNSN08383A1 (en) | 2009-12-29 |
AU2007234917B2 (en) | 2011-05-12 |
JP2009532494A (ja) | 2009-09-10 |
EP2004167A1 (en) | 2008-12-24 |
WO2007118023A1 (en) | 2007-10-18 |
RU2008143055A (ru) | 2010-05-10 |
CN101415413A (zh) | 2009-04-22 |
AU2007234917A1 (en) | 2007-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202208783B (en) | Kras mutant protein inhibitors | |
DE60329001D1 (en) | 8-hydroxychinolinderivate | |
MX2009004984A (es) | Metodos para conservar la funcion renal utilizando inhibidores de oxidoreductasa de xantina. | |
IL193252A0 (en) | N-hydroxyacrylamide compounds | |
WO2007019153A3 (en) | Methods for treating hypertension | |
WO2008024439A3 (en) | 4-aminoquinazoline derivatives and methods of use thereof | |
WO2008033798A3 (en) | A pyrrolopyrazin as syk-kinase inhibitor | |
MX2007004020A (es) | Uso de inhibidores de renina para la prevencion o tratamiento de disfuncion diastolica o falla cardiaca diastolica. | |
MY153243A (en) | Compound for inhibiting mitotic progression | |
WO2010108074A3 (en) | Inhibitors of pi3 kinase | |
WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
UA95955C2 (ru) | Ингибиторы обратной транскриптазы вич | |
WO2008077057A3 (en) | Cytoskeletal active rho kinase inhibitor compounds, composition and use | |
MX2012002752A (es) | Compuestos de heteroarilo como inhibidores de cinasa. | |
MX346186B (es) | Inhibidores de proteina cinasas. | |
IL178100A0 (en) | 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension | |
GEP20125708B (en) | Hydroxamate-based inhibitors of deacetylases b | |
WO2007056324A3 (en) | Combination of an angiotensin ii receptor blocker, a calcium channel blocker and another active agent | |
WO2008064866A8 (en) | Treatment for multiple myeloma | |
WO2006124684A3 (en) | Combination therapy comprising a taxane and a thymidylate synthase inhibitor | |
WO2008109991A8 (en) | Inhibitors of carnitine palmitoyltransferase and treating cancer | |
WO2009086426A3 (en) | Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction | |
WO2007044325A3 (en) | Apoe4 domain interaction inhibitors and methods of use thereof | |
TNSN08383A1 (en) | Renin inhibitors for the treatment of hypertension | |
WO2007046842A3 (en) | Composition for inhibition of cathepsin k |